Treatment method

Details for Australian Patent Application No. 2005292033 (hide)

Owner Ariad Gene Therapeutics, Inc.

Inventors Bedrosian, Camille L.

Agent Davies Collison Cave

Pub. Number AU-A-2005292033

PCT Pub. Number WO2006/039414

Priority 60/615,485 30.09.04 US

Filing date 30 September 2005

Wipo publication date 13 April 2006

International Classifications

A61K 31/198 (2006.01)

A61K 31/33 (2006.01) - Heterocyclic compounds

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/039414 Priority application(s): WO2006/039414

11 June 2009 Assignment before Grant

  Ariad Gene Therapeutics, Inc. The application has been assigned to ARIAD Pharmaceuticals, Inc.

16 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005292046-Methods and apparatuses for aesthetically enhanced image conversion

2005292029-Artificial intervertebral disc nucleus